264
Participants
Start Date
August 1, 2016
Primary Completion Date
May 31, 2018
Study Completion Date
December 31, 2018
Northern Westchester Hospital Association, Mount Kisco
Northshore Hematology Oncology, East Setauket
Gettysburg Cancer Center, Gettysburg
Christiana Care Health Services Inc, Newark
Virginia Cancer Institute, Richmond
East Carolina University, Greenville
Levine Cancer Center, Mint Hill
Pinehurst Medical Clinic, Pinehurst
Carolina Blood and Cancer Care, Rock Hill
Mid-Florida Hematology and Oncology Centers, Orange City
Holy Cross Hospital, Fort Lauderdale
Tennessee Cancer Specialists, Knoxville
The West Clinic, Germantown
Jackson Oncology Associates, PLLC, Jackson
Norton Healthcare Inc, Louisville
Henry Ford Allegiance Health, Jackson
Park Nicolett, Saint Louis Park
Trinity Cancer Center, Minot
Edward M Kaplan, MD & Associates, Skokie
Swedish Covenant Hospital, Chicago
Washington University (St. Louis), St Louis
Boone Hospital Center, Columbia
Cotton O'Neil Clinical Research Center, Topeka
Nebraska Methodist Hospital, Omaha
Christus Cancer Treatment Center, Shreveport
Hope Cancer Center of East Texas (Tyler Hem Onc), Tyler
Thomas Spann Clinic Oncology, Corpus Christi
University of Colorado Cancer Center, Aurora
Facey Medical Foundation, Mission Hills
Providence Health and Services, Portland
University of Washington (Swedish General), Seattle
Providence Regional Medical Center, Everett
Northwest Medical Specialties, Tacoma
Eastern CT Hematology Oncology, Norwich
Berkshire Hematology Oncology Services, Pittsfield
Lead Sponsor
Collaborators (1)
Vector Oncology
OTHER
Inivata
INDUSTRY